Both Trx 1 and TrxR1 are increased in prostate cancer [15, 16], with a greater proportion of Trx 1 in an oxidized state, which may reflect redox imbalance and response to greater levels of oxidative stress. Here, TXNRD1 is linked to prostate carcinoma.